Replimune Group, Inc.

REPL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$11.91+6.34%

2026-08-03

Financials

Valuation Metrics

Replimune Group, Inc.'s Market Cap is $983M. At end of 2025 it was $896M. Ranked #2506 of 3,112 in US market (top 81%), #1033 of 1,445 on NASDAQ (top 71%), #193 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 72%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$983M	US#2,506/3,112 Sec#193/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-314M	US—/3,112 Sec—/269
Total Assets	$332M	US#2,867/3,112 Sec#198/269
Net Assets	$166M	US#2,787/3,112 Sec#209/269
Value
P/B	5.92x	US#2,300/3,112 Sec#154/269
FCF Yield	-28.94%	US—/3,112 Sec—/269
Profitability
ROE	-188.94%	US#2,906/3,112 Sec#235/269
ROA	-94.45%	US#3,044/3,112 Sec#263/269
Financial Health
Debt Ratio	100.04%	US#1,096/3,112 Sec#170/269
Total Debt	$28M	US#2,655/3,112 Sec#170/269
FCF	$-285M	US#2,777/3,112 Sec#235/269
Cash	$209M	US#1,689/3,112 Sec#111/269
Current Ratio	4.79x	US#497/3,112 Sec#150/269
Performance
1Y Return	56.71%	US#264/3,112 Sec#72/269
1M Return	2.85%	US#1,233/3,112 Sec#52/269
From 52W High	-5.48%	US#606/3,112 Sec#24/269
1Y MDD	-86.54%	US#3,091/3,112 Sec#265/269
Trading
Volume	10,235,202 shares	US#161/3,112 Sec#11/269
Trading Value	$118M	US#812/3,112 Sec#47/269
Per Share
EPS	$-3.42	US—/3,112 Sec—/269
BPS	$2.28	US#2,480/3,112 Sec#169/269